SE8601963L - O-sulfaterade beta-laktamhydroxamsyror - Google Patents

O-sulfaterade beta-laktamhydroxamsyror

Info

Publication number
SE8601963L
SE8601963L SE8601963A SE8601963A SE8601963L SE 8601963 L SE8601963 L SE 8601963L SE 8601963 A SE8601963 A SE 8601963A SE 8601963 A SE8601963 A SE 8601963A SE 8601963 L SE8601963 L SE 8601963L
Authority
SE
Sweden
Prior art keywords
hydroxamic acids
sulphated
beta
lactam hydroxamic
lactam
Prior art date
Application number
SE8601963A
Other languages
English (en)
Swedish (sv)
Other versions
SE8601963D0 (sv
Inventor
J E Sundeen
W H Koster
R Zahler
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8601963D0 publication Critical patent/SE8601963D0/xx
Publication of SE8601963L publication Critical patent/SE8601963L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE8601963A 1985-04-29 1986-04-28 O-sulfaterade beta-laktamhydroxamsyror SE8601963L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/728,432 US4638060A (en) 1985-04-29 1985-04-29 O-sulfated spiro β-lactam hydroxamic acids

Publications (2)

Publication Number Publication Date
SE8601963D0 SE8601963D0 (sv) 1986-04-28
SE8601963L true SE8601963L (sv) 1986-10-30

Family

ID=24926831

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601963A SE8601963L (sv) 1985-04-29 1986-04-28 O-sulfaterade beta-laktamhydroxamsyror

Country Status (20)

Country Link
US (1) US4638060A (xx)
JP (1) JPS61257965A (xx)
AU (1) AU601944B2 (xx)
BE (1) BE904699A (xx)
CA (1) CA1273938A (xx)
CH (1) CH668073A5 (xx)
DE (1) DE3614317A1 (xx)
DK (1) DK190286A (xx)
ES (1) ES8800916A1 (xx)
FI (1) FI861693A (xx)
FR (1) FR2581062B1 (xx)
GB (1) GB2174392B (xx)
HU (1) HU194822B (xx)
IE (1) IE59630B1 (xx)
IT (1) IT1215652B (xx)
NL (1) NL8601051A (xx)
NZ (1) NZ215665A (xx)
PT (1) PT82467B (xx)
SE (1) SE8601963L (xx)
ZA (1) ZA862429B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN113975396B (zh) * 2021-11-09 2022-11-29 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260743A (en) * 1979-12-31 1981-04-07 Gist-Brocades N.V. Preparation of β-lactams and intermediates therefor
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS586589A (ja) 1981-07-01 1983-01-14 Hitachi Ltd 論理回路
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規２−アゼチジノン誘導体

Also Published As

Publication number Publication date
NZ215665A (en) 1988-11-29
IT8620227A0 (it) 1986-04-28
FR2581062B1 (fr) 1990-10-19
CA1273938C (en) 1990-09-11
IT1215652B (it) 1990-02-22
ES8800916A1 (es) 1987-12-01
IE59630B1 (en) 1994-03-09
JPS61257965A (ja) 1986-11-15
IE861067L (en) 1986-10-29
CH668073A5 (fr) 1988-11-30
DK190286A (da) 1986-10-30
DE3614317A1 (de) 1986-11-06
ES554438A0 (es) 1987-12-01
DK190286D0 (da) 1986-04-24
AU601944B2 (en) 1990-09-27
FI861693A (fi) 1986-10-30
PT82467A (en) 1986-05-01
GB8609596D0 (en) 1986-05-21
NL8601051A (nl) 1986-11-17
AU5556886A (en) 1986-11-06
ZA862429B (en) 1986-11-26
PT82467B (pt) 1988-03-03
US4638060A (en) 1987-01-20
GB2174392B (en) 1988-11-09
HUT41384A (en) 1987-04-28
SE8601963D0 (sv) 1986-04-28
BE904699A (fr) 1986-08-18
HU194822B (en) 1988-03-28
FR2581062A1 (fr) 1986-10-31
GB2174392A (en) 1986-11-05
CA1273938A (en) 1990-09-11
FI861693A0 (fi) 1986-04-22

Similar Documents

Publication Publication Date Title
FI914928A (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
FI845126A0 (fi) Nya pyridin-2-etrar och pyridin-2-tioetrar med en kvaevehaltig cykloalifatisk ring.
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
FI863836A (fi) Kinolinderivat.
EP0177940A3 (en) Hydrazine derivatives and their use
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
SE8601963L (sv) O-sulfaterade beta-laktamhydroxamsyror
CA1271748C (en) BENZAZEPINE DERIVATIVES
DK366084D0 (da) Antibiotikum
ATE140460T1 (de) Echinocandin-b-derivat
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
SE8701019L (sv) Makrolidforening
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
DK248484A (da) Isoquinolinderivater
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
PT83712B (pt) Processo para a preparacao de derivados de cefalosporina
JPS6110461B2 (xx)
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
SE9000857D0 (sv) Novel use of theraeutically active compound
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8601963-5

Effective date: 19900803

Format of ref document f/p: F